Christopher Kenney

2.8k total citations
32 papers, 2.0k citations indexed

About

Christopher Kenney is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Christopher Kenney has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Christopher Kenney's work include Neurological disorders and treatments (20 papers), Parkinson's Disease Mechanisms and Treatments (19 papers) and Genetic Neurodegenerative Diseases (8 papers). Christopher Kenney is often cited by papers focused on Neurological disorders and treatments (20 papers), Parkinson's Disease Mechanisms and Treatments (19 papers) and Genetic Neurodegenerative Diseases (8 papers). Christopher Kenney collaborates with scholars based in United States, Switzerland and Canada. Christopher Kenney's co-authors include Joseph Jankovic, Christine Hunter, Anthony Davidson, Richard K. Simpson, Joseph Jankovic, Robert A. Hauser, Joohi Jimenez‐Shahed, Susan H. Fox, William G. Ondo and James Poysky and has published in prestigious journals such as The Journal of Immunology, Neurology and The Lancet Neurology.

In The Last Decade

Christopher Kenney

32 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Kenney United States 21 1.3k 749 275 205 187 32 2.0k
Olof Sydow Sweden 26 1.1k 0.8× 896 1.2× 535 1.9× 133 0.6× 104 0.6× 49 2.0k
Hortensia Alonso‐Navarro Spain 29 1.4k 1.1× 552 0.7× 510 1.9× 322 1.6× 339 1.8× 148 2.6k
Cindy Casteels Belgium 26 584 0.4× 1.0k 1.4× 391 1.4× 122 0.6× 247 1.3× 70 2.1k
Lora Clawson United States 24 1.8k 1.3× 689 0.9× 592 2.2× 59 0.3× 86 0.5× 36 2.6k
Qianqian Wei China 28 2.0k 1.5× 521 0.7× 623 2.3× 183 0.9× 253 1.4× 210 2.8k
Subrata K. Bose United Kingdom 14 673 0.5× 343 0.5× 341 1.2× 288 1.4× 379 2.0× 18 1.6k
Chris C. Tang United States 28 1.7k 1.2× 729 1.0× 302 1.1× 205 1.0× 667 3.6× 70 2.6k
Ruwei Ou China 27 1.9k 1.4× 466 0.6× 503 1.8× 158 0.8× 357 1.9× 204 2.6k
Andréas Moser Germany 22 411 0.3× 600 0.8× 317 1.2× 111 0.5× 286 1.5× 94 1.3k
Lorenzo Kiferle Italy 20 871 0.6× 551 0.7× 196 0.7× 125 0.6× 184 1.0× 30 1.3k

Countries citing papers authored by Christopher Kenney

Since Specialization
Citations

This map shows the geographic impact of Christopher Kenney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Kenney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Kenney more than expected).

Fields of papers citing papers by Christopher Kenney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Kenney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Kenney. The network helps show where Christopher Kenney may publish in the future.

Co-authorship network of co-authors of Christopher Kenney

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Kenney. A scholar is included among the top collaborators of Christopher Kenney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Kenney. Christopher Kenney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernandez, Hubert H., Daniel Weintraub, Eric A. Macklin, et al.. (2023). Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial. Parkinsonism & Related Disorders. 114. 105511–105511. 6 indexed citations
2.
3.
Olanow, C. Warren, Christopher Kenney, Stephen I. Bandak, & Karl Kieburtz. (2018). Adverse event reporting in clinical trials in Parkinson's Disease: Time for change. Movement Disorders. 33(11). 1685–1687. 2 indexed citations
4.
Lenderking, William R., Sally Mannix, Jennifer Petrillo, et al.. (2015). Assessment of Parkinson’s disease levodopa-induced dyskinesia: a qualitative research study. Quality of Life Research. 24(8). 1899–1910. 2 indexed citations
5.
Rascol, Olivier, Susan H. Fox, F. Gasparini, et al.. (2014). Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. Parkinsonism & Related Disorders. 20(9). 947–956. 88 indexed citations
6.
Hauser, Robert A., C. Warren Olanow, Karl Kieburtz, et al.. (2014). Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial. The Lancet Neurology. 13(8). 767–776. 103 indexed citations
7.
Ferrara, Joseph M., et al.. (2009). Efficacy and tolerability of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover trial. Journal of the Neurological Sciences. 285(1-2). 195–197. 33 indexed citations
8.
Jankovic, Joseph, et al.. (2008). Relationship between various clinical outcome assessments in patients with blepharospasm. Movement Disorders. 24(3). 407–413. 116 indexed citations
9.
Zhang, Jing, Izabela Sokal, Elaine R. Peskind, et al.. (2008). CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases. American Journal of Clinical Pathology. 129(4). 526–529. 223 indexed citations
10.
Kenney, Christopher, Christine Hunter, Anthony Davidson, & Joseph Jankovic. (2008). Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia. The Journal of Clinical Pharmacology. 48(3). 379–384. 56 indexed citations
11.
Kuo, Sheng‐Han, Christopher Kenney, & Joseph Jankovic. (2008). Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Movement Disorders. 23(4). 616–619. 53 indexed citations
12.
Kenney, Christopher, Alan Diamond, Nicte I. Mejia, et al.. (2007). Distinguishing psychogenic and essential tremor. Journal of the Neurological Sciences. 263(1-2). 94–99. 56 indexed citations
13.
Kenney, Christopher, Richard K. Simpson, Christine Hunter, et al.. (2007). Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. Journal of neurosurgery. 106(4). 621–625. 154 indexed citations
14.
Diamond, Alan, Christopher Kenney, Michael Almaguer, & Joseph Jankovic. (2007). Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Journal of neurosurgery. 107(5). 1036–1038. 14 indexed citations
15.
Kenney, Christopher & Joseph Jankovic. (2007). Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. Journal of Neural Transmission. 115(4). 585–591. 91 indexed citations
16.
Kenney, Christopher, Christine Hunter, Anthony Davidson, & Joseph Jankovic. (2006). Short‐term effects of tetrabenazine on chorea associated with Huntington's disease. Movement Disorders. 22(1). 10–13. 43 indexed citations
17.
Kenney, Christopher, Suzanne Z. Powell, & Joseph Jankovic. (2006). Autopsy‐proven Huntington's disease with 29 trinucleotide repeats. Movement Disorders. 22(1). 127–130. 62 indexed citations
18.
Diamond, Alan, Christopher Kenney, & Joseph Jankovic. (2006). Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy. Movement Disorders. 21(8). 1273–1275. 23 indexed citations
19.
Kenney, Christopher, Christine Hunter, & Joseph Jankovic. (2006). Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Movement Disorders. 22(2). 193–197. 128 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olof Sydow Breakdown of academic impact, for papers by Hortensia Alonso‐Navarro Breakdown of academic impact, for papers by Cindy Casteels Breakdown of academic impact, for papers by Lora Clawson Breakdown of academic impact, for papers by Qianqian Wei Breakdown of academic impact, for papers by Subrata K. Bose Breakdown of academic impact, for papers by Chris C. Tang Breakdown of academic impact, for papers by Ruwei Ou Breakdown of academic impact, for papers by Andréas Moser Breakdown of academic impact, for papers by Lorenzo Kiferle
Rankless by CCL
2026